ACB Articles, Aurora Cannabis Inc.

President Joe Biden's shaky debate performance this week is stirring doubts among Democrats about his viability for reelection. As doubts&...

Aurora Cannabis (NASDAQ: ACB), a key player in the global medical marijuana market, stands at a strategic crossroads. Pablo Zuanic, a seasoned mari...

The financial landscapes of Canadian and U.S. cannabis operators showcase distinct paths in the quest for profitability, driven by varying market d...

Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) announced its financial and operational results Thursday for the fourth quarter and fiscal year 2024. T...

A short squeeze forces investors betting on a stock's decline (short sellers) to buy back shares at a higher price to avoid losses, triggering ...

The medical cannabis packaging market is undergoing rapid expansion, forecasted to catapult from $6.5 billion in 2023 to a staggering $117.2 billio...

Lawmakers in Germany have set a maximum allowed limit of THC – the psychoactive substance found in the cannabis plant – for drivers to have...

Canadian cannabis giant Aurora Cannabis Inc.(NASDAQ:ACB) (TSX:ACB) in conjunction with MedReleaf Australia, is launching its premium 1.2g resin car...

As the 19th Benzinga Cannabis Capital Conference returns to Chicago (Oct. 8-9), gathering top CEOs, investors and leaders in the marijuana industry...

In a recent report, Pablo Zuanic of Zuanic & Associates analyzed trends in Canada's recreational cannabis market through May 2024. The repo...